|  | Intervention group | Control group | No | ICC |  | ||
---|---|---|---|---|---|---|---|---|
 |  | Score (SD) | No | Score (SD) | No |  |  | Adjusted mean difference** (95% CI); p***-value |
SF-36 scales* | Â | Â | Â | Â | Â | Â | Â | Â |
Physical functioning | Baseline | 52.2 (27.7) | 77 | 45.5 (27.8) | 64 | Â | Â | Â |
 | Seven months | 44.9 (28.9) | 77 | 43.6 (26.3) | 64 | 141 | 0 | -3.3 (-9.7 to 3.1); 0.30 |
Role functioning, physical | Baseline | 42.5 (44.4) | 67 | 34.3 (41.3) | 54 | Â | Â | Â |
 | Seven months | 31.3 (41.5) | 75 | 37.9 (43.5) | 60 | 119 | 0.12 | -5.9 (-19.7 to 7.8); 0.30 |
Bodily pain | Baseline | 63.2 (27.9) | 76 | 60.5 (29.5) | 64 | Â | Â | Â |
 | Seven months | 58.5 (29.9) | 76 | 53.8 (29.2) | 64 | 139 | 0.000 | 3.6 (-5.6 to 12.7); 0.43 |
General health perceptions | Baseline | 48.3 (17.8) | 77 | 44.2 (19.2) | 63 | Â | Â | Â |
 | Seven months | 44.9 (18.6) | 74 | 44.3 (18.2) | 64 | 137 | 0.000 | -2.0 (-7.5 to 3.6); 0.47 |
Vitality | Baseline | 43.9 (21.3) | 75 | 43.9 (22.5) | 63 | Â | Â | Â |
 | Seven months | 39.0 (21.3) | 77 | 43.1 (20.4) | 63 | 137 | 0.070 | -4.1 (-11.1 to 2.7); 0.22 |
Social functioning | Baseline | 75.3 (23.2) | 77 | 67.3 (27.4) | 63 | Â | Â | Â |
 | Seven months | 64.0 (31.4) | 77 | 64.8 (28.9) | 64 | 140 | 0.10 | -5.6 (-16.8 to 5.6); 0.31 |
Role functioning, emotional | Baseline | 65.9 (45.2) | 68 | 66.0 (46.0) | 54 | Â | Â | Â |
 | Seven months | 56.3 (47.0) | 71 | 60.3 (46.5) | 58 | 117 | 0.000 | -2.6 (-18.1 to 12.9); 0.73 |
Mental health | Baseline | 62.3 (20.2) | 75 | 66.0 (20.3) | 62 | Â | Â | Â |
 | Seven months | 58.9 (21.7) | 77 | 63.8 (20.0) | 63 | 136 | 0.002 | -1.8 (-8.0 to 4.4); 0.56 |
KCCQ* overall summary | ||||||||
 | Baseline | 66.7 (20.9) | 78 | 63.6 (20.2) | 60 |  |  | -2.4 (-9.3 to 4.4); 0.47 |
 | Seven months | 64.0 (23.7) | 78 | 65.3 (20.9) | 64 |  |  |  |
EHFScBs**** | Â | Â | Â | Â | Â | Â | Â | Â |
 | Baseline | 24.4 (7.8) | 90 | 23.8 (7.5) | 70 |  |  | 1.3 (-0.9 to 3.5); 0.24 |
 | Seven months | 24.1 (7.9) | 76 | 23.6 (6.8) | 64 |  |  |  |
EUROPEP***** | Â | Â | Â | Â | Â | Â | Â | Â |
 | Baseline | 105.8 (9.3) | 90 | 106.2 (8.7) | 69 |  |  | -0.5 (-4.1 to 3.2); 0.80 |
 | Seven months | 104.8 (10.4) | 77 | 104.5 (10.8) | 63 |  |  |  |
PHQ-9****** | Â | Â | Â | Â | Â | Â | Â | Â |
sum score | Baseline | 7.4 (5.6) | 91 | 7.4 (5.8) | 76 | Â | Â | Â |
 | Seven months | 8.6 (5.9) | 77 | 7.4 (5.4) | 63 |  |  | 0.8 (-0.7 to 2.3); 0.30 |
 |  |  |  |  |  |  |  | adjusted odds ratio******* (95% CI); p***-value |
No. (%) of Major Depressive Syndromes | Baseline | 12 (15.6) | 77 | 7 (11.1) | 63 | Â | Â | Â |
 | Seven months | 14 (18.2) | 77 | 8 (12.7) | 63 |  |  | 1.5 (0.5 to 4.6); 0.48 |